NCT01978600View on ClinicalTrials.gov

Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

Brinzolamide 1%/Brimonidine 0.2% ophthalmic suspension

Commercially marketed and approved for lowering IOP in patients with open-angle glaucoma and ocular hypertension.

DRUG

Timolol Maleate 0.5%

Commercially marketed and approved for lowering IOP in patients with open-angle glaucoma and ocular hypertension.

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY